Target Selectivity of Adavosertib (AZD1775, MK-1775)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| Wee1 | 5.2 nM | in vitro kinase assays | PMC10363032 |
| pCDK1 | 240 nM | non-clinical data | PMC10345044 |
| CYP3A | 14 μM | -- | PMC10363032 |
Check the
Adavosertib (AZD1775, MK-1775)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Adavosertib (AZD1775, MK-1775) Mechanism of Action: WEE1 Inhibition in Ovarian Cancer Cell Research
- Adavosertib (AZD1775, MK-1775) Clinical Trials
- Adavosertib (AZD1775, MK-1775) Working Concentration | Cell Culture | Treatment
- Adavosertib (AZD1775, MK-1775) Solubility in DMSO
- Adavosertib (AZD1775, MK-1775) Stock Solution
- Adavosertib (AZD1775, MK-1775) Storage
- Adavosertib (AZD1775, MK-1775) Stability
- Adavosertib (AZD1775, MK-1775) Combination Database
- Adavosertib (AZD1775, MK-1775) Molecular Weight
- Adavosertib (AZD1775, MK-1775) SMILES
- Adavosertib (AZD1775, MK-1775) CAS Number
- Adavosertib (AZD1775, MK-1775) Chemical Structure (2D and 3D)
- Adavosertib (AZD1775, MK-1775) IC50 for Cell-based and Cell-free Assays
- Adavosertib (AZD1775, MK-1775) Sigma (BL3H1F1C7CA8)? Try a better option.
- Adavosertib (AZD1775, MK-1775) MedChemExpress (HY-10993)? Try a better option.
- Adavosertib (AZD1775, MK-1775) Tocris (7589)? Try a better option.
- Adavosertib (AZD1775, MK-1775) CST (69589)? Try a better option.
- Adavosertib (AZD1775, MK-1775) SDS｜MSDS